EDITORIAL SECTION

Articles

Designing Early-stage Formulation Strategies for Anti-microbial Peptides (Amps): A Major Prerequisite for Combating Anti-microbial Resistance

At present the world is witnessing an exponential increase in antimicrobial resistance AMR making it important for us to search alternatives to antibiotics in order to combat multidrug resistant MDR bacterial infections According to a study drugresistant infections were responsible for million deaths in globally The number of predicted deaths

Radical Optionality to Leadership Reinvention: Dual Framework for Biotech-CDMO Transformation

Biotech and CDMOs stand at a pivotal crossroads On one side scientific complexity is acceleratingnew modalities such as antibodydrug conjugates mRNA oligonucleotides and cell and gene therapies demand faster more adaptive development models On the other side systemic pressures are tighteningthe biotech funding squeeze the Biosecure Act and fractured global supply chains are forcing organisations t...

The Role of European Pharma in Global Healthcare Advancements

Europe is one of the largest players in the international market for health care due to research development and innovation and competitive pharmaceutical industries Some of these European pharma medical research organizations and health care systems have continually provided valuable solutions to the welfare of people globally It is an increasingly important role for them to play given that they...

Business Transformation Strategies for the Pharmaceutical Industry

The pharmaceutical industry is at a crossroads Drug development timelines remain long regulatory scrutiny keeps intensifying and patients now expect the same seamless digital experiences they get from banking apps or online retailers Against this backdrop pharma business transformation has moved from a nicetohave to a survival requirement

From Lab to Market: The Journey of a New Drug

The process of synthesizing a new drug takes many years and several phases and all of them are important for the drug safety and efficacy Which from the first identification in a lab to the final approval of use by the public is a process that takes over years and this involves work done by scientists various agencies and other health care givers

Unveiling Hope: Progress and Challenges in Rare Disease Drug Development

Rare diseases often referred to as orphan diseases affect a small percentage of the population Despite their rarity these diseases collectively impact millions of people worldwide The development of drugs

Techno Trends

USF Researchers Identify New P. vivax Vaccine Target

Researchers at USF Health have identified a previously unknown vulnerability in Plasmodium vivax a major malaria parasite found across parts of Asia and Central and South America

Projects

Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia

Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys